Financial Summary (All financials)
| In millions, except per share items | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-13 | Dec-31-12 | Dec-31-11 |
| Revenues | 0 | 0 | 0 | 480 | 1,351 | 1,550 |
| Revenue growth | | | | -64.5% | -12.8% | |
| Cost of goods sold | 0 | 0 | 0 | 454 | 853 | 1,055 |
| Gross profit | 0 | 0 | 0 | 26 | 498 | 495 |
| Gross margin | | | | 5.4% | 36.9% | 31.9% |
| Selling, general and administrative | 0 | 0 | 0 | 59 | 250 | 290 |
| Research and development | | | | 193 | 1,165 | 1,065 |
| EBIT | 0 | 0 | 0 | -252 | -2,037 | -875 |
| EBIT margin | | | | -52.5% | -150.8% | -56.5% |
| Pre-tax income | 0 | 0 | 0 | -260 | -2,083 | -901 |
| Income taxes | 0 | 0 | 0 | 9 | 11 | 128 |
| Net income | 0 | 0 | 0 | -269 | -2,093 | -1,029 |
| Net margin | | | | -56.0% | -154.9% | -66.4% |
| |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|